1
|
Lu L, Zhang Y, Angley M, Bejerano S, Brockman JD, McClure LA, Unverzagt FW, Fly AD, Kahe K. Association of Urinary Cadmium Concentration With Cognitive Impairment in US Adults: A Longitudinal Cohort Study. Neurology 2024; 103:e209808. [PMID: 39231381 PMCID: PMC11373676 DOI: 10.1212/wnl.0000000000209808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/06/2024] Open
Abstract
BACKGROUND AND OBJECTIVES Studies have indicated that cadmium (Cd) exposure is associated with neurotoxicity. However, data linking Cd exposure to cognitive impairment are sparse. We aimed to investigate the association between urinary Cd concentration and cognitive impairment in US adults. METHODS The REasons for Geographic and Racial Differences in Stroke (REGARDS) study is an ongoing population-based prospective cohort study that enrolled 30,239 Black and White US adults aged 45 years or older at baseline (2003-2007). In a randomly selected subcohort of REGARDS participants who were free of cognitive impairment or stroke at baseline, certain trace element concentrations, including urinary creatinine-corrected Cd, were measured using biospecimens collected and stored at baseline. During an average of 10 years of follow-up, global cognitive impairment was assessed annually using the Six-Item Screener, and domain-based cognitive impairment, including verbal learning, memory, and executive function, was evaluated every other year using the Enhanced Cognitive Battery. Multivariable-adjusted logistic regression models were used to examine the association between urinary Cd concentration and the odds of global or domain-based cognitive impairment. RESULTS A total of 2,172 participants (mean age: 64.1 ± 9.0 years; female: 54.8%; Black participants: 38.7%) with available data on urinary Cd concentration, including 195 cases of global cognitive impairment and 53 cases of domain-based cognitive impairment, were included in the analyses. While there was no association between Cd and cognitive impairment in the full sample, there was a significant positive association of urinary Cd concentration with global cognitive impairment among White but not Black participants. The odds of cognitive impairment for White participants in the high urinary Cd concentration group (≥median) were doubled compared with those in the low urinary Cd group (odds ratio 2.07, 95% CI 1.18-3.64). Sex, age, region, smoking pack-years, alcohol consumption, and other related metals did not materially modify the associations of interest. DISCUSSION Findings from this prospective cohort study suggest that urinary Cd concentrations are associated with global cognitive impairment among White but not Black individuals. Further studies with repeatedly measured Cd exposure, larger sample sizes, and longer duration are needed to confirm our findings and explore the potential explanations for the observed racial discrepancy, such as the impact of smoking.
Collapse
Affiliation(s)
- Liping Lu
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - Yijia Zhang
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - Meghan Angley
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - Shai Bejerano
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - John D Brockman
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - Leslie A McClure
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - Frederick W Unverzagt
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - Alyce D Fly
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| | - Ka Kahe
- From the Department of Obstetrics and Gynecology (L.L., Y.Z., M.A., S.B., K.K.), Vagelos College of Physicians and Surgeons, and Department of Epidemiology (L.L., Y.Z., M.A., K.K.), Mailman School of Public Health, Columbia University, New York, NY; Department of Nutrition and Health Science (L.L., A.D.F.), College of Health, Ball State University, Muncie, IN; Department of Chemistry (J.D.B.), University of Missouri, Columbia; College for Public Health & Social Justice (L.A.M.), Saint Louis University, MO; and Department of Psychiatry (F.W.U.), Indiana University School of Medicine, Indianapolis
| |
Collapse
|
2
|
Cheung ESL, Zhang Z. Moderating Role of Neighborhood Environment in the Associations Between Hearing Loss and Cognitive Challenges Among Older Adults: Evidence From US National Study. Res Aging 2024; 46:400-413. [PMID: 38361482 DOI: 10.1177/01640275241234372] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/17/2024]
Abstract
This study examined the associations between hearing loss and cognitive challenges among community-dwelling older adults and whether neighborhood characteristics (physical disorder and low social cohesion) moderated the associations. Cross-sectional national data from Round 11 of the National Health and Aging Trends Study were adopted (N = 2,515). Multinomial logistic regressions were used to examine associations among variables and interactive analyses were conducted to examine moderating effects. Results indicated significant relationships between the experience of hearing loss and possible dementia and between severe or profound hearing loss and probable dementia. Interactive models suggested that residing in neighborhoods with physical disorder and low social cohesion were negatively associated with possible dementia among older adults with moderate and severe or profound hearing loss, respectively, compared to those without hearing loss. Findings underscore the necessity of environmental and social interventions to enhance cognitive health among older adults with varying degrees of hearing challenges.
Collapse
Affiliation(s)
| | - Zhe Zhang
- Teachers College, Columbia University, New York, NY, USA
| |
Collapse
|
3
|
Matisāne L, Paegle DI, Paegle L, Akūlova L, Matisāne M, Vanadziņš I. Can Occupational Safety and Health Preventive Measures Taken by the Employer Influence Sleep Disturbances in Teleworkers? Results from the Quantitative Study on Working Life with COVID-19 in Latvia. Brain Sci 2024; 14:684. [PMID: 39061424 PMCID: PMC11275139 DOI: 10.3390/brainsci14070684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2024] [Revised: 07/03/2024] [Accepted: 07/05/2024] [Indexed: 07/28/2024] Open
Abstract
This research on sleep disturbances emerged during the COVID-19 pandemic. Our study investigated the association between self-reported sleep disturbances among teleworkers and the preventive measures employers took to improve their working environment. Answers obtained via a web survey gathered from 1086 teleworkers (517 in the spring of 2021 and 569 in the spring of 2022) were analysed. The odds of self-reported sleep disturbances were significantly higher for all preventive measures in the group of respondents reporting a lack of a particular measure. The highest odds ratios were observed for the statement "My employer identified conditions where I am teleworking" (adjusted OR = 2.98, 95% CI 2.10-4.23) and "Online team-building events were organised" (adjusted OR = 2.85, 95% CI 1.88-4.35). The results of our study have revealed that workplace interventions that serve as a mediator for sleep disorders, even if they are not directly targeted at managing sleep disturbances or stress, can reduce the number of teleworkers reporting sleep disturbances. According to our knowledge, this is the first study reporting the effectiveness of employer interventions that help teleworkers manage their sleep disturbances.
Collapse
Affiliation(s)
- Linda Matisāne
- Institute of Occupational Safety and Environmental Health, Rīga Stradiņš University, Dzirciema 16, LV-1007 Riga, Latvia; (D.I.P.); (L.P.); (L.A.); (M.M.); (I.V.)
| | | | | | | | | | | |
Collapse
|
4
|
Lyamin OI, Borshchenko VD, Siegel JM. A 108-h total sleep deprivation did not impair fur seal performance in delayed matching to sample task. J Comp Physiol B 2024; 194:315-333. [PMID: 37596419 PMCID: PMC11296610 DOI: 10.1007/s00360-023-01511-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 08/05/2023] [Accepted: 08/07/2023] [Indexed: 08/20/2023]
Abstract
While the majority of studies have concluded that sleep deprivation causes detrimental effects on various cognitive processes, some studies reported conflicting results. We examined the effects of a 108-h total sleep deprivation (TSD) on working memory in the northern fur seal, an animal with unusual sleep phenomenology and long-range annual migrations. The performance of fur seals was evaluated in a two-choice visual delayed matching to sample (DMTS) task, which is commonly used to evaluate working memory. In baseline conditions, the performance of fur seals in a DMTS task based on the percentage of errors was somewhat comparable with that in nonhuman primates at similar delays. We have determined that a 108-h TSD did not affect fur seals' performance in a visual DMTS task as measured by overall percentage of errors and response latencies. On the contrary, all fur seals improved task performance over the study, including the baseline, TSD and recovery conditions. In addition, TSD did not change the direction and strength of the pattern of behavioral lateralization in fur seals. We conclude that a 108-h TSD did not interfere with working memory in a DMTS test in northern fur seals.
Collapse
Affiliation(s)
- Oleg I Lyamin
- Department of Psychiatry, University of California Los Angeles, Center for Sleep Research, 16111 Plummer St, North Hills, Los Angeles, CA, 91343, USA.
- A.N. Severtsov Institute of Ecology and Evolution, Moscow, Russia.
| | - Vasilisa D Borshchenko
- I.M. Sechenov Institute of Evolutionary Physiology and Biochemistry, St Petersburg, Russia
| | - Jerome M Siegel
- Department of Psychiatry, University of California Los Angeles, Center for Sleep Research, 16111 Plummer St, North Hills, Los Angeles, CA, 91343, USA
| |
Collapse
|
5
|
Somelar-Duracz K, Jürgenson M, Viil J, Zharkovsky A, Jaako K. 'Unpredictable chronic mild stress does not exacerbate memory impairment or altered neuronal and glial plasticity in the hippocampus of middle-aged vitamin D deficient mice'. Eur J Neurosci 2024; 59:1696-1722. [PMID: 38269959 DOI: 10.1111/ejn.16256] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Revised: 12/10/2023] [Accepted: 01/02/2024] [Indexed: 01/26/2024]
Abstract
Vitamin D deficiency is a worldwide health concern, especially in the elderly population. Much remains unknown about the relationship between vitamin D deficiency (VDD), stress-induced cognitive dysfunctions and depressive-like behaviour. In this study, 4-month-old male C57Bl/6J mice were fed with control or vitamin D free diet for 6 months, followed by unpredictable chronic stress (UCMS) for 8 weeks. VDD induced cognitive impairment and reduced grooming behaviour, but did not induce depressive-like behaviour. While UCMS in vitamin D sufficient mice induced expected depressive-like phenotype and impairments in the contextual fear memory, chronic stress did not manifest as an additional risk factor for memory impairments and depressive-like behaviour in VDD mice. In fact, UCMS restored self-care behaviour in VDD mice. At the histopathological level, VDD mice exhibited cell loss in the granule cell layer, reduced survival of newly generated cells, accompanied with an increased number of apoptotic cells and alterations in glial morphology in the hippocampus; however, these effects were not exacerbated by UCMS. Interestingly, UCMS reversed VDD induced loss of microglial cells. Moreover, tyrosine hydroxylase levels decreased in the striatum of VDD mice, but not in stressed VDD mice. These findings indicate that long-term VDD in adulthood impairs cognition but does not augment behavioural response to UCMS in middle-aged mice. While VDD caused cell loss and altered glial response in the DG of the hippocampus, these effects were not exacerbated by UCMS and could contribute to mechanisms regulating altered stress response.
Collapse
Affiliation(s)
- Kelli Somelar-Duracz
- Institute of Biomedicine and Translational Medicine, Department of Pharmacology, University of Tartu, Tartu, Estonia
| | - Monika Jürgenson
- Institute of Biomedicine and Translational Medicine, Department of Pharmacology, University of Tartu, Tartu, Estonia
| | - Janeli Viil
- Institute of Biomedicine and Translational Medicine, Department of Pharmacology, University of Tartu, Tartu, Estonia
| | - Alexander Zharkovsky
- Institute of Biomedicine and Translational Medicine, Department of Pharmacology, University of Tartu, Tartu, Estonia
| | - Külli Jaako
- Institute of Biomedicine and Translational Medicine, Department of Pharmacology, University of Tartu, Tartu, Estonia
| |
Collapse
|
6
|
Xu C, Song Y, Sempionatto JR, Solomon SA, Yu Y, Nyein HYY, Tay RY, Li J, Heng W, Min J, Lao A, Hsiai TK, Sumner JA, Gao W. A physicochemical-sensing electronic skin for stress response monitoring. NATURE ELECTRONICS 2024; 7:168-179. [PMID: 38433871 PMCID: PMC10906959 DOI: 10.1038/s41928-023-01116-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Accepted: 12/19/2023] [Indexed: 03/05/2024]
Abstract
Approaches to quantify stress responses typically rely on subjective surveys and questionnaires. Wearable sensors can potentially be used to continuously monitor stress-relevant biomarkers. However, the biological stress response is spread across the nervous, endocrine, and immune systems, and the capabilities of current sensors are not sufficient for condition-specific stress response evaluation. Here we report an electronic skin for stress response assessment that non-invasively monitors three vital signs (pulse waveform, galvanic skin response and skin temperature) and six molecular biomarkers in human sweat (glucose, lactate, uric acid, sodium ions, potassium ions and ammonium). We develop a general approach to prepare electrochemical sensors that relies on analogous composite materials for stabilizing and conserving sensor interfaces. The resulting sensors offer long-term sweat biomarker analysis of over 100 hours with high stability. We show that the electronic skin can provide continuous multimodal physicochemical monitoring over a 24-hour period and during different daily activities. With the help of a machine learning pipeline, we also show that the platform can differentiate three stressors with an accuracy of 98.0%, and quantify psychological stress responses with a confidence level of 98.7%.
Collapse
Affiliation(s)
- Changhao Xu
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
- These authors contributed equally to this work
| | - Yu Song
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
- These authors contributed equally to this work
| | - Juliane R. Sempionatto
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
- These authors contributed equally to this work
| | - Samuel A. Solomon
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
- These authors contributed equally to this work
| | - You Yu
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
| | - Hnin Y. Y. Nyein
- Department of Chemical and Biological Engineering, Hong Kong University of Science and Technology, Hong Kong, China
| | - Roland Yingjie Tay
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
| | - Jiahong Li
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
| | - Wenzheng Heng
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
| | - Jihong Min
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
| | - Alison Lao
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
| | - Tzung K. Hsiai
- Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
| | - Jennifer A. Sumner
- Department of Psychology, University of California, Los Angeles, CA, USA
| | - Wei Gao
- Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, California Institute of Technology, Pasadena, CA, USA
| |
Collapse
|
7
|
Iwai T, Mishima R, Hirayama S, Nakajima H, Oyama M, Watanabe S, Fujii H, Tanabe M. SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis. J Clin Med 2024; 13:608. [PMID: 38276114 PMCID: PMC10817044 DOI: 10.3390/jcm13020608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2023] [Revised: 01/18/2024] [Accepted: 01/19/2024] [Indexed: 01/27/2024] Open
Abstract
The δ opioid receptor (DOR) inverse agonist has been demonstrated to improve learning and memory impairment in mice subjected to restraint stress. Here, we investigated the effects of SYK-623, a new DOR inverse agonist, on behavioral, immunohistochemical, and biochemical abnormalities in a mouse model of imipramine treatment-resistant depression. Male ddY mice received daily treatment of adrenocorticotropic hormone (ACTH) combined with chronic mild stress exposure (ACMS). SYK-623, imipramine, or the vehicle was administered once daily before ACMS. After three weeks, ACMS mice showed impaired learning and memory in the Y-maze test and increased immobility time in the forced swim test. SYK-623, but not imipramine, significantly suppressed behavioral abnormalities caused by ACMS. Based on the fluorescent immunohistochemical analysis of the hippocampus, ACMS induced a reduction in astrocytes and newborn neurons, similar to the reported findings observed in the postmortem brains of depressed patients. In addition, the number of parvalbumin-positive GABA neurons, which play a crucial role in neurogenesis, was reduced in the hippocampus, and western blot analysis showed decreased glutamic acid decarboxylase protein levels. These changes, except for the decrease in astrocytes, were suppressed by SYK-623. Thus, SYK-623 mitigates behavioral abnormalities and disturbed neurogenesis caused by chronic stress.
Collapse
Affiliation(s)
- Takashi Iwai
- Laboratory of Pharmacology, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (T.I.); (R.M.); (H.N.); (M.O.); (S.W.)
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
| | - Rei Mishima
- Laboratory of Pharmacology, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (T.I.); (R.M.); (H.N.); (M.O.); (S.W.)
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
| | - Shigeto Hirayama
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
- Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
| | - Honoka Nakajima
- Laboratory of Pharmacology, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (T.I.); (R.M.); (H.N.); (M.O.); (S.W.)
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
| | - Misa Oyama
- Laboratory of Pharmacology, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (T.I.); (R.M.); (H.N.); (M.O.); (S.W.)
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
| | - Shun Watanabe
- Laboratory of Pharmacology, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (T.I.); (R.M.); (H.N.); (M.O.); (S.W.)
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
| | - Hideaki Fujii
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
- Laboratory of Medicinal Chemistry, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan
| | - Mitsuo Tanabe
- Laboratory of Pharmacology, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (T.I.); (R.M.); (H.N.); (M.O.); (S.W.)
- Medicinal Research Laboratories, School of Pharmacy, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan; (S.H.); (H.F.)
| |
Collapse
|
8
|
De Looze C, McCrory C, O'Halloran A, Polidoro S, Anne Kenny R, Feeney J. Mind versus body: Perceived stress and biological stress are independently related to cognitive decline. Brain Behav Immun 2024; 115:696-704. [PMID: 37977246 DOI: 10.1016/j.bbi.2023.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Revised: 10/17/2023] [Accepted: 10/22/2023] [Indexed: 11/19/2023] Open
Abstract
Chronic stress may increase risk of age-related cognitive decline. 'Stress', however, is a multidimensional construct and few studies have investigated the inter-relationship of subjective stress and biological stress with cognitive decline. In this study, we examine the relationship between perceived stress and two measures of biological stress - allostatic load, indexing stress at the physiological level and leukocyte telomere length, indexing stress at the cellular level - with cognitive decline over a 12-year period in adults aged 50 and older. 3,458 participants (aged ≥ 50) from The Irish Longitudinal study on Ageing with measurements of allostatic load, telomere length and perceived stress at baseline and repeated measures of cognitive function were included. Hierarchical linear regression models with adjustment for multiple potential confounders were applied, and repeated stratified by sex in sensitivity analyses. Higher perceived stress at baseline was associated with lower cognitive function (β = -0.10, 95 % CI -0.12, -0.07, p <.001), with similar strength of associations across waves. There were significant interactions between measures of biological stress and wave; higher allostatic load was associated (X2(18) = 64.4; p <.001), and telomere length was borderline (X2(18) = 9.4; p =.09) associated with cognitive decline from 4-year follow-up onward. Sex stratified analyses revealed that the association between telomere length and cognitive decline was present in women only. Mutual adjustment did not attenuate associations in either case. The interactions between allostatic load and telomere length with perceived stress were not significant. Our findings suggest that subjective measures of stress and biological metrics may be independently related to cognitive function over time in older adults, hinting at the potential for different underlying mechanisms.
Collapse
Affiliation(s)
- Céline De Looze
- The Irish Longitudinal Study on Ageing (TILDA), School of Medicine, Trinity College Dublin, Dublin, Ireland.
| | - Cathal McCrory
- The Irish Longitudinal Study on Ageing (TILDA), School of Medicine, Trinity College Dublin, Dublin, Ireland
| | - Aisling O'Halloran
- The Irish Longitudinal Study on Ageing (TILDA), School of Medicine, Trinity College Dublin, Dublin, Ireland
| | | | - Rose Anne Kenny
- The Irish Longitudinal Study on Ageing (TILDA), School of Medicine, Trinity College Dublin, Dublin, Ireland; Mercer's Institute for Successful Ageing (MISA), St James's Hospital, Dublin, Ireland
| | - Joanne Feeney
- The Irish Longitudinal Study on Ageing (TILDA), School of Medicine, Trinity College Dublin, Dublin, Ireland
| |
Collapse
|
9
|
Chintapalli R, Myint PK, Brayne C, Hayat S, Keevil VL. Lower mental health related quality of life precedes dementia diagnosis: findings from the EPIC-Norfolk prospective population-based study. Eur J Epidemiol 2024; 39:67-79. [PMID: 37904062 PMCID: PMC10811145 DOI: 10.1007/s10654-023-01064-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2022] [Accepted: 10/16/2023] [Indexed: 11/01/2023]
Abstract
Lower Health Related Quality of Life (HRQoL) precedes dementia in older adults in the USA. We explore prospective associations between HRQoL and dementia in British adults in mid and late-life, when interventions to optimise cognitive ageing may provide benefit. 7,452 community-dwelling participants (57% women; mean age 69.3 ± 8.3 years) attended the European Prospective Investigation of Cancer-Norfolk study's third health check (3HC) and reported their HRQoL using Short-Form 36 (SF-36). Cox Proportional Hazard regression models explored associations between standard deviation differences in baseline Physical Component (PCS) and Mental Component Summary (MCS) scores, as well as eight SF-36 sub-scales (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, mental health), and incident dementia over ten years. Logistic regression models explored cross-sectional relationships at the 3HC between HRQoL and objective global cognitive function (n = 4435; poor cognition = lowest performance decile). The cohort was examined as a whole and by age-group (50-69, ≥ 70), considering socio-demographics and co-morbidity. Higher MCS scores were associated with lower chance of incident dementia (Hazard Ratio [HR] = 0.74, 95% CI 0.68-0.81) and lower odds of poor cognition (Odds Ratio [OR] = 0.82, 0.76-0.89), with findings similar by age-group. Higher PCS scores were not associated with dementia in the whole cohort (HR = 0.93, 0.84-1.04) or considering age-groups; and were only associated with poor cognition in younger participants (OR = 0.81, 0.72-0.92). Similarly, associations between higher scores on subscales pertaining to mental, but not physical, HRQoL and lower dementia incidence were observed. Lower mental HRQoL precedes dementia diagnosis in middle-aged and older British adults.
Collapse
Affiliation(s)
- Renuka Chintapalli
- School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, England, UK.
| | - Phyo K Myint
- Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, UK
| | - Carol Brayne
- Cambridge Public Health, Department of Psychiatry, University of Cambridge, Herchel Smith Building, Forvie Site, Cambridge Biomedical Campus, Cambridge, CB2 0SZ, England, UK
| | - Shabina Hayat
- Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, England, UK
| | - Victoria L Keevil
- Department of Medicine, University of Cambridge, Level 5 Addenbrooke's Hospital, Hills Road, Cambridge, England, UK
- Medicine for the Elderly, Addenbrooke's Hospital, Hills Road, Cambridge, England, UK
| |
Collapse
|